Internal Medicine, Hematology & Oncology · Massillon, OH
NPI
1043215676
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
7337 Caritas Cir NW
Massillon, OH, 44646
Phone (330) 478-0001
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.1M
232,490 services
Medicare patients, 2024
780
Average age 75
Drug cost, 2024
$16.9M
3,915 prescriptions
Company payments, 2025
$4,597
From 61 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Noman Rafique was code J1439 (injection, ferric carboxymaltose, 1 mg), 75,750 times for 69 patients. In total Noman Rafique billed 232,490 services in 140 codes, and Medicare paid $3.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 75,750 | 69 | $0.86 | $65K |
| J0897 Injection, denosumab, 1 mg | Office | 15,000 | 100 | $20.41 | $306K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 12,000 | 30 | $4.25 | $51K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 10,600 | 13 | $44.62 | $473K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,740 | 15 | $6.50 | $18K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,520 | 42 | $0.09 | $223 |
| 85025 Blood Count | Office | 2,486 | 601 | $7.56 | $19K |
| 36415 Venipuncture Blood Collection | Office | 2,381 | 609 | $8.60 | $20K |
| 99214 Office E&M - Established | Office | 983 | 347 | $97.49 | $96K |
| 80053 Clinical Chemistry | Office | 833 | 402 | $10.30 | $8,578 |
| 96372 Injection Administration | Office | 615 | 180 | $10.94 | $6,730 |
| 99213 Office E&M - Established | Office | 510 | 349 | $61.11 | $31K |
| 83615 Clinical Chemistry | Office | 449 | 188 | $5.89 | $2,643 |
| 96413 Chemotherapy Administration | Office | 418 | 73 | $98.42 | $41K |
| 96367 Intravenous Infusion, Hydration | Office | 388 | 50 | $22.09 | $8,572 |
By year: 2022 $2.9M for 223,621 services; 2023 $2.8M for 224,338 services; 2024 $3.1M for 232,490 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,486 | 601 | $7.56 | $19K |
| 36415 Venipuncture Blood Collection | 2,381 | 609 | $8.60 | $20K |
| 80053 Clinical Chemistry | 833 | 402 | $10.30 | $8,578 |
| 83615 Clinical Chemistry | 449 | 188 | $5.89 | $2,643 |
| 82728 Clinical Chemistry | 319 | 187 | $13.25 | $4,225 |
| 83540 Clinical Chemistry | 308 | 183 | $6.28 | $1,935 |
| 83550 Clinical Chemistry | 308 | 183 | $8.49 | $2,616 |
| 85610 Clinical Chemistry | 147 | 12 | $4.20 | $617 |
| 82306 Clinical Chemistry | 117 | 84 | $28.58 | $3,344 |
| 82607 Clinical Chemistry | 94 | 83 | $14.50 | $1,363 |
Medicare prescription drug claims, 2024
In 2024, the drug Noman Rafique prescribed most often to Medicare patients was Anastrozole, with 306 prescriptions and refills. In total Noman Rafique wrote 3,915 Medicare prescriptions that cost $16.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 306 | 667 | 84 | $4,509 |
| Eliquis Apixaban | 268 | 298 | 51 | $169K |
| Acyclovir Generic | 175 | 243 | 40 | $2,245 |
| Ondansetron Hcl Generic | 134 | 134 | 52 | $11K |
| Xtandi Enzalutamide | 118 | 118 | 14 | $1.6M |
| Gabapentin Generic | 109 | 131 | 30 | $898 |
| Hydroxyurea Generic | 108 | 189 | 32 | $2,253 |
| Xarelto Rivaroxaban | 105 | 135 | 21 | $73K |
| Rolvedon Eflapegrastim-Xnst | 91 | 91 | 18 | $397K |
| Levothyroxine Sodium Generic | 82 | 126 | 23 | $553 |
| Prednisone Generic | 82 | 90 | 35 | $285 |
| Potassium Chloride Generic | 70 | 82 | 38 | $543 |
| Somatuline Depot Lanreotide Acetate | 69 | 69 | Under 11 | $575K |
| Lenalidomide Generic | 67 | 67 | 13 | $898K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 59 | 59 | Under 11 | $303K |
Brand drugs: - claims; generic drugs: 2,268 claims; opioid claims: 114.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Noman Rafique $4,597 ($4,597 in general payments such as food, travel and fees) from 61 companies. The largest payer was Janssen Biotech, Inc. with $1,560.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 7 | $1,560 |
| Merck Sharp & Dohme LLC MRK | 6 | $234 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $190 |
| Daiichi Sankyo Inc. 4568.T | 9 | $161 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $156 |
| Pfizer Inc. PFE | 13 | $156 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $122 |
| Celgene Corporation BMY | 6 | $121 |
| Eisai Inc. 4523.T | 4 | $109 |
| Abbvie Inc. ABBV | 5 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.